摘要：
2024年1月13日, 北京大学药学院天然药物及仿生药物全国重点实验室吕万良教授团队在著名学术期刊Bioactive Materials (IF = 18.9)在线发表了题为Gene engineered exosome reverses T cell exhaustion in cancer immunotherapy的研究工作。
Supporting:
北京大学药学院 天然药物及仿生药物全国重点实验室. 吕万良团队在基因工程化PD1蛋白制剂用于肿瘤免疫治疗研究取得进展[J]. 中国药学(英文版), 2024, 33(2): 178-179.
State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center. The research group of Prof. Wanliang Lu has made progress in the research of genetically engineered PD1 protein preparations in cancer immunotherap[J]. Journal of Chinese Pharmaceutical Sciences, 2024, 33(2): 178-179.
>
>